• Home
  • >
  • Vanta Bioscience Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/v.svg Logo

Vanta Bioscience Ltd Financial Statement

Vanta Bioscience Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2023Dec 2022Mar 2022
Revenue4.091.714.11
Operating Expense4.261.382.54
Net Profit-2.73-1.51-0.17
Net Profit Margin-66.75-88.3-4.14
Earning Per Share-4.32-2.39-0.27
EBIDTA-0.190.311.54
Effective Tax RateTBATBA-2.55

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Vanta Bioscience Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual6.289.6910.04
Operating Expenses Annual8.676.226.09
Operating Profit Annual-1.713.893.98
Interest Annual5.892.352.14
Depreciation2.11.321.25
Net Profit Annual-6.480.090.45
Tax Annual0.180.090.14

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Vanta Bioscience Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning0.222.650.2
Cash Flow from Operations-0.635.286.97
Cash Flow from Investing-5.91-17.24-22.3
Cash Flow from Financing6.419.5317.78
Cash Flow at the End0.10.222.65

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Vanta Bioscience Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)-27.0740.1439.64
PBIT Margin (%)-69.5926.5227.19
PBT Margin (%)-55.2814.8614.44
Net PROFIT Margin (%)-82.010.864.68
Return On Networth / Equity (%)TBA0.541.9
Return On Networth /Employed(%)TBA3.995.42
Return On Assets (%)-6.560.120.89
Total Debt / Equity(X)1.060.790.66
Asset Turnover Ratio (%)0.080.140.19

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Vanta Bioscience Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual67.8341.8129.39
Total Current Assets Annual15.2414.519.94
Non Current Assets Annual69.4766.9149.69
Total Shareholders Funds Annual17.5124.0123.92
Total Assets Annual84.7181.469.63

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Vanta Bioscience Ltd Earning Calls
Mar 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Vanta Bioscience Ltd has a market capitalization of 36.29 Cr. Value Research classifies it as a Micro-Cap company.

No, Vanta Bioscience Ltd is not debt-free with a debt-to-equity ratio of 3.26.

In FY 2023, Vanta Bioscience Ltd recorded a total revenue of approximately 6.28 Cr marking a significant milestone in the company's financial performance.

Vanta Bioscience Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and -0.2% annually, respectively..

Vanta Bioscience Ltd's current PE ratio is -5.60.

Vanta Bioscience Ltd's ROCE averaged 0.9% from the FY ending March 2021 to 2023, with a median of 3.7%. It peaked at 4.9% in March 2021, reflecting strong capital efficiency over the period..

Vanta Bioscience Ltd's latest EBIT is Rs. -4.37 Cr, surpassing the average EBIT of Rs. 0.31 Cr over the 5 years..